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Erythrina variegata L. (Fam. Fabaceae) is traditionally known for antitumour, expectorant, febrifuge, antibacterial and 
antioxidant activities. In the present study, we did cytotoxic evaluation of the methanol extract of E. variegata stem bark 
(MEV) using 3-(4,5-dimethyl thazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay in MCF-7 and MDA-MB-231 
human breast carcinoma cell lines. The cytological and metabolic alterations due to MEV was evaluated using acridine 
orange/ethidium bromide (AO/EB) dual staining, hoechst 33258 and fluoroprobe, benzimidazol-carbocyanine iodide 
5,5',6,6'-tetrachloro-1,1',3,3'-tetra ethyl (JC-1) staining. The antiapoptotic gene and protein, Bcl-2 expression was analysed 
using real time PCR and Western blotting, respectively. The methanol extract was investigated for the presence of various 
phytochemicals using gas chromatography high resolution mass spectrometry (GC-HRMS). The results revealed a dose 
dependent cytotoxic activity in both MDA-MB-231 and MCF-7 breast carcinoma cell lines in vitro. The plant extract was 
effective in inducing apoptotic cell death via mitochondrial dependent intrinsic pathway and may be considered as a potent 
source for isolating therapeutic molecules against cancer.  
Keywords: Anticancer, Antitumour, B-cell lymphoma-2, GC-HRMS, Indian coral tree, Mitochondria 
Cancer is emerging as a key barrier to rising life 
expectancy and a prominent cause of death in almost 
all parts of World
1
. The prevalence and death rates of 
cancer is undergoing a swift growth worldwide and 
affects the socioeconomic development of population 
also
2
. Breast cancer, a complex, heterogeneous and 
invasive disease, is the most diagnosed cancer 
subtypes among other cancers with an occurrence of 
23 lakh new cases globally
3
. According to WHO, 
breast cancer is the second leading cause of cancer 
death in women
4
. Among the various types of breast 
cancers, about 70 to 80% are hormone-dependent
5
 and 
10 to 14% are hormone-independent
6
. The hike has 
been attributed to reproductive, lifestyle risk factors 
and increasing trend of deliberate mammographic 
diagnosis. Wider gap between menarche and 
menopause, higher age of first birth, less breast-
feeding, menopausal hormone therapy are the 
predisposing reproductive factors involved. Lifestyle 
changes like increased consumption of alcohol, 
obesity and lack of exercise are also a contributing 
factor for the transition
7
. Majority of novel anticancer 
medications are cytotoxic agents or targeted 
biologicals which inflict cell viability, inhibit cellular 




Herbal drugs are gaining popularity and researchers 
look into natural resources for safe alternative drugs, 
particularly for anticancer compounds. Medicinal 
herbs and their by-products could bestow upon 
conventional and subsidiary treatment modalities 
affirmed by the current research in cancer 
subpopulations. They are also believed to elevate the 
potency of existing drugs which might diminish their 
adverse effects in persons undergoing cancer 
treatment. Henceforth, the phyto drug development 
requires a consistent research to sequester novel 
effective compounds with least toxicity
9-15
. 
The study concentrates on the discovery of novel 
herbal derivatives which can contribute as a 
trustworthy alternative for cancer treatment. Erythrina 
variegata, Linn. commonly known as Indian Coral 
Tree, is known for its antitumour, expectorant, 
febrifuge, antibacterial and antioxidant activities
16,17
. 
Although there are meagre reports on antitumour 
activity of the plant, a comprehensive understanding 
on how the plant acts at a cellular and molecular level 
is not known. Hence, in the present research work 
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focuses is on evaluation of anticancer properties of  
E. variegata in breast carcinoma cell lines and 
developing discernment towards the phytoconstituents 
involved in the action. 
 
Materials and Methods 
 
Chemicals and drugs 
Acridine orange, agarose, acrylamide, dihydrogen 
sodium phosphate, ethylene diamine tetra acetic acid 
(EDTA), methyl thiazolyl diphenyl-tetrazolium 
bromide (MTT), N1,N1-dimethyl bisacrylamide, 
proteinase K, RNAse A, Tween 20, Triton-X-100, 
dimethyl sulphoxide (DMSO), antibiotic antimycotic 
solution (100X), doxorubicin, monoclonal anti-Bcl-2 
clone Bcl-2-100 and monoclonal anti beta actin 
antibody were purchased from Sigma-Aldrich 
Chemical Co. (St. Louis, MO, USA). RPMI 1640, 
FBS and Trypsin/EDTA were purchased from 
Invitrogen Life Technologies, USA. Horse radish 
peroxidase-conjugated secondary antimouse 
antibodies were purchased from Cell Signalling 
Technology, Danvers, MA, USA. 
 
Collection of plant material and authentication 
The stem bark of E. variegata was collected from 
the premises of Rabbit Breeding Station, College of 
Veterinary and Animal Sciences, Mannuthy, Thrissur 
district, Kerala. The plant material was taxonomically 
identified and authenticated by Research and P.G. 
Department of Botany, St. Thomas College 
(Autonomous), Thrissur, Kerala, India and the 
voucher specimen has been deposited in the 
Department of Veterinary Pharmacology and 
Toxicology, College of Veterinary and Animal 




The stem bark of E. variegata was air dried at 
room temperature and coarsely powdered using an 
electric pulverizer. The powder obtained was 
extracted using a Soxhlet apparatus with methanol at 
55℃. The methanol extract was then concentrated 
using a rotary vacuum evaporator under reduced 
pressure and temperature (55℃) and kept under 
refrigeration after complete evaporation of the solvent 
in an airtight container. 
 
Sample preparation 
The methanol extract was solubilized in dimethyl 
sulphoxide (DMSO) at a concentration of 1.0 mg/mL, 
further this stock solution was diluted with  
sterile PBS to required concentrations. The final 
concentration of DMSO in the well was maintained 
less than one per cent w/v.  
 
Culturing of cell lines 
MDA-MB-231 and MCF-7 cell lines were 
procured from the Cell Repository, National Centre 
for Cell Sciences, Pune, India. The cells were  
cultured in RPMI-1640 supplemented with 10%  
foetal bovine serum and 4% antibiotic antimycotic 
solution containing penicillin-streptomycin and 
amphotericin B. The cells were maintained in a 
humidified incubator at 37°C with 5% CO2. The  
cells were subcultured by enzymatic digestion  
with 0.25% trypsin and 1 mM ethylene diamine 
tetraacetic acid solution after attaining 70% 
confluency. Trypsinized cells were used for  
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) assay. 
 
In vitro cytotoxic study of MEV 
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) assay was done to assess 
the cytotoxicity of MEV as per the method of  
Naidu et al.
18
. The MCF-7 and MDA-MB-231 breast 
cancer cell lines were seeded at a density of 5×10
3
 
cells per well in 200 µL medium, and were allowed to 
attach for overnight in a CO2 incubator. Cells were 
treated with methanol extract at concentrations of 2.5, 
5, 10, 20, 40, 80, 160 and 320 µg/mL for a period of 
48 h. After the treatment, 20 µL of MTT (5 mg/mL) 
in 150 µL medium was added and incubated at 37℃  
for 4 h after removing the medium with extract of  
E. variegata. Then the media with MTT was removed 
and the formed purple formazan crystals were 
dissolved in 200 µL of DMSO and read at 570 nm  
in an ELISA plate reader (Varioskan flash, Thermo 
Fischer Scientific, Finland). 
The per cent cell viability was calculated using the 
formula:  
Per cent cell viability = (Average absorbance of 
treated cells /Average absorbance of untreated cells) × 
100.  
The half maximal inhibitory concentration (IC50) 
values of extract were calculated by plotting the 
concentration against per cent cell viability using the 
online software ―very simple IC50 tool kit‖. 
 
Selection of concentrations 
Based on the MTT assay, three concentrations of 
the plant extract was selected for the study: one below 
IC50, IC50 and one above IC50 which were 7.5, 15,  
30, and 11.5, 23, 46 µg/mL for MDA-MB-231 and 
MCF-7 cells, respectively. 





Trypsinized cells at concentration of 1×10
5
 cells 
were seeded into a six well plate and allowed to  
grow for 24 h. Based on the MTT assay, three 
concentrations of the plant extract was selected for the 









staining techniques were used for staining. 
Doxorubicin at a dose of 0.58 μg/mL was adopted as 
positive control. 
 
Microscopic studies using acridine orange ethidium bromide 
The acridine orange ethidium bromide (AO/EB) 
staining procedure was followed to differentiate the 
live, apoptotic and necrotic cells. 25 µL of the treated 
or untreated cells were stained with 5 µL of acridine 
orange (10 µg/mL) and ethidium bromide (10 µg/mL) 
and analysed under Trinocular Research fluorescence 
Microscope, DM 2000 LED, Leica with blue 
excitation (488 nm) and emission (550 nm) filters at 
20X magnification. 
 
Analysis of morphological changes in nucleus 
MCF-7 and MDA-MB-231 cells (1×10
5
 cells per 
well) were seeded in six well plates and after 24 h of 
growth, cells were treated with the above mentioned 
concentrations of extract for 24 h. Cells were fixed 
with methanol for 30 min after washing with PBS and 
then stained with Hoechsht 33258 stain (Invitrogen  
35 µg/mL) for 30 min. Images were captured by 
Trinocular Research fluorescence Microscope, DM 
2000 LED, Leica microscope with blue excitation 
(352 nm) and emission (461 nm) filters at 20X 
magnification. The per cent apoptotic cells were 
assessed by counting number of apoptotic cells in six 
different microscopic fields after hoechst 33258 
staining. 
 
Analysis of mitochondrial transmembrane potential (MMP)  
MCF-7 and MDA-MB-231 cells were plated at a 
seeding density of 1×10
5
 cells per well in six well 
plates. After 24 h of treatment with extract at the 
above mentioned concentrations, cells were incubated 
with 5 µM JC-1 for 30 min at 30℃ in the dark. The 
cells were analysed using fluorescent microscope with 
filters having blue excitation/ emission of 540/570 nm 
and red excitation/ emission of 590/610 nm filters 
(DM 2000 LED, Leica). 
 
B cell lymphoma-2 (Bcl-2) gene expression study 
The technique of real time quantitative polymerase 
chain reaction (RT-qPCR) was employed for studying 
the gene expression of Bcl-2 gene in cell culture 
samples. Briefly, the cells were treated with the 
extract at its respective IC50 concentration for 24 h. 
RNA was obtained from control and extract treated 
cells using Gen Elute mammalian total RNA kit 
(Sigma- Aldrich, USA) as per manufacturer‘s 
instruction with slight modifications. The obtained 
RNA was DNase treated using DNase kit (Sigma- 
Aldrich, USA). Complementary DNA (cDNA) 
synthesis was carried out from total RNA (500 ng) 
using Revert Aid first strand cDNA synthesis kit 
(Thermoscientific, USA) as per manufacturer‘s 
protocol. The reaction mixture was then subjected  
to PCR for amplification of Bcl-2 gene using 
specifically designed primers by online Primer  
three primer design software (Primer three, 
http://bioinfo.ut.ee/primer3/) (Bcl-2 Forward: 5'-TGG 
ATCCAGGATAACGGAGG-3', Bcl-2 Reverse:  
5'-CAAACAGAGGTCGCATGCTG-3'). The house-
keeping gene GAPDH (Forward: 5'-CAACGAATTT 
GGCTACAGCA-3', Reverse: 5'-AGGGGAGATTCA 
GTGTGGTG-3') was co-amplified in each reaction as 
an internal control. The Quantitative real time PCR 
was carried out in a final volume of 20 µL containing 
250 ng of template cDNA, Maxima SYBR green 
qPCRmastermix (12.5 µL) and 10 pM/ µL of each 
primer. In negative control, template cDNA was 
replaced by DEPC water. Separate PCR reactions 
were set up for target gene and housekeeping 
gene/reference (GAPDH). Each sample was run in 
triplicate in 20 µL reaction. The cycling conditions 
were 4 min initial incubation at 95°C and 40 cycles of 
amplification cycle with denaturation at 95⁰C, 
annealing 61°C (Bcl-2) and 58°C (GAPDH) for 40 s, 
extension 72°C for 35 s, and terminated with an 
additional extension step for one min at 72°C . 
The relative change in expression of Bcl-2 gene 
was analysed by comparative CT (Cycle threshold) 
method
22
 and was expressed as ‗n‘ fold change up/ 
down regulation of the transcripted gene in relation to 




where ∆∆CT = (CT target gene - CT GAPDH) 
treatment-(CT target gene-CT, GAPDH) control. 
 
Western blot analysis 
Western blot analysis was done as per the method 
of Shrivasthava et al.
23
. After treatment of cells with 
extract at its respective IC50 concentrations for 24 h, 
cells were collected and washed twice in 1X PBS, 
then lyzed in radio immunoprecipitation assay (RIPA) 




buffer with protease and phosphatase inhibitors on ice 
for 1.0 h. Cell lysates were then centrifuged for  
15 min at 18,728 g at 4⁰C. Proteins were separated 
using 12% sodium dodecyl sulphated- polyacrylamide 
gel electrophoresis (SDS-PAGE). The gel after 
electrophoresis was immersed in transfer buffer for  
15 min. The proteins were subsequently transferred to 
PVDF (polyvinylidene difluoride) membrane (0.45 µm) 
using Hoefer Semi dry transfer apparatus as per 
manufacturer‘s instructions. The blots were blocked 
with 5% bovine serum albumin (BSA) in tris buffered 
saline tween -20 (TBST) at room temperature for 1.0 h. 
Then the membranes were washed thrice with TBST 
for 10 min. After overnight incubation at 4⁰C with 
respective primary antibodies, the membrane was 
washed thrice in TBST for 10 min each. After 
washing with TBST, the blots were incubated with 
horse radish peroxidase conjugated secondary 
antibody for 1 h. The unbound conjugate was 
removed by washing thrice with TBST. Colour 
reaction was carried out with 10 mL of DAB substrate 
buffer with an incubation of 10 min. The reaction was 
stopped by washing the membrane in triple distilled 
water. To ensure equal protein loading, β actin was used 
as an internal control. The strength of western blotting 
bands was determined by Image J density Measurement 
program (http://imagej.en.softonic.com). 
 
Gas chromatography-high resolution mass spectroscopy  
(GC-HRMS) analysis 
The active phytochemical principles of MEV  
was analysed using gas chromatography- high 
resolution mass spectrometry (GC-HRMS) system of 
Sophisticated Analytical Instrument Facility (SAIF), 
Indian Institute of Technology (IIT), Bombay. Gas 
chromatography (Agilent, USA, 7890) with FID 
detector, EI/CI source and time of flight analyser with 
a mass range of 10-2000 amu and a mass resolution of 
6000 was used. Helium was used as the carrier gas at 
flow rate of 1.0 mL/ min. The oven temperature was 
maintained at 70⁰C for one min and then increased to 
200⁰C in five min. The injector temperature was 
250⁰C and total analysis time was 50 min. 0.4 µL 
aliquots of extracts were injected into the 
chromatographic column after a clear baseline had 
been obtained. Major constituents were identified  






All results were expressed as Mean ± SE with n 
equal to number of replicates. The half maximal 
inhibitory concentration (IC50) values of extract were 
calculated using the online software ―Very Simple 
IC50 Tool Kit‖. All the statistical analysis was 
conducted using SPSS software version 21. The 
variation between groups for apoptotic cell per cent 
were assessed by one-way analysis of variance 
(ANOVA) followed by Duncan‘s multiple comparison 
test. Expression fold change in gene and protein 




In vitro cytotoxic study of MEV 
The data of MTT reduction assay of E. variegata 
extract in MDA-MB-231 and MCF-7 tumour cell 
lines are presented in Fig. 1. The per cent cell 
viability of MEV showed a drastic reduction in cell 
viability after 20 μg/mL and was in a constant range 
in both MDA-MB-231 and MCF-7 tumour cells for 
further concentrations in a similar pattern. The half 
maximal inhibitory concentration (IC50) for methanol 
extract of E. variegata were found to be 14.99±0.59 
and 22.94±3.19 μg/mL for MDA-MB-231 cells and 
MCF-7 cells, respectively.  
 
Microscopic studies 
Acridine orange/ethidium bromide dual (AO/EB) staining 
After treatment with extract, live, necrotic, early 
and late apoptotic cells were detected. Figs 2 and 3 
depicted representative images of cells of treatments 
after AO/EB staining. Control cells were live with 
centrally distributed circular nucleus and were 
emitting greenish fluorescence. Below IC50 
concentrations of extract in both cell lines were early 
apoptotic cells with localized crescent-shaped or 
 
 
Fig. 1 — The per cent cell viability of MDA-MB-231 and MCF-7 
cells after 48 h treatment with methanol extract of Erythrina 
variegata determined by MTT reduction assay. [Values are 
expressed as Mean ± SE (n=3)] 




granular yellow-green stained nucleus. At IC50 and 
above IC50 concentrations, majority of cells were in 
late apoptotic stage emitting orange to red 
fluorescence. A few necrotic cells and some early 
apoptotic cells were present. Cellular changes like 
membrane blebbing, nuclear fragmentation, 
chromatin condensation and apoptotic bodies were 
also detected. Majority of doxorubicin control cells 
also were in late apoptotic stage.  
 
Analysis of morphological changes in nucleus 
Both control cells were live emitting uniform blue 
fluorescence. Positive control cells and cells treated 
with various concentrations of plant extract were 
showing apoptotic features like fragmented and 
marginalised nuclei and condensed chromatin  
(Figs 4 and 5). Apoptotic cell per cent increased 
significantly (P <0.01) in a concentration dependent 




Fig. 2 — Morphological changes of MDA-MB-231 cells by acridine orange ethidium bromide staining, 200X. (A) control cells; (B) Cells 
treated with doxorubicin 0.58 μg/mL; (C-E) cells treated with methanol extract of Erythrina variegata at concentrations 7.5, 15 and  
30 μg/mL, respectively. [Green arrow- normal cells White arrow - early apoptotic cells, Yellow arrow-late apoptotic cells, Blue arrow 




Fig. 3 — Morphological changes of MCF-7 cells by acridine orange ethidium bromide staining, 200X. (A) control cells; (B) Cells treated 
with doxorubicin 0.58 μg/mL; (C-E) cells treated with methanol extract of E. variegata at concentrations 11.5, 23 and 46 μg/mL, 
respectively. [Green arrow- normal cells White arrow - early apoptotic cells, Yellow arrow-late apoptotic cells, Blue arrow indicates 




Fig. 4 — Morphological changes of MDA-MB-231 cells by hoechst staining, 200X. (A) control cells; (B) Cells treated with doxorubicin 
0.58 μg/mL; (C--E) cells treated with methanol extract of E. variegata at concentrations 7.5, 15 and 30 μg/mL, respectively. [White arrow 
– live cells, Red arrow- apoptotic cells, Yellow arrow- chromatin condensation, green arrow-marginalisation of nucleus, orange arrow-




Fig. 5 — Morphological changes of MCF-7 cells by Hoechst staining, 200X. (A) control cells; (B) Cells treated with doxorubicin  
0.58 μg/mL; (C-E)- cells treated with methanol extract of E. variegata at concentrations 11.5, 23 and 46 μg/mL, respectively. [White 
arrow – live cells, Red arrow- apoptotic cells, Yellow arrow- chromatin condensation, green arrow-marginalisation of nucleus, orange 
arrow-fragmentation of nuclei] 
 




Analysis of mitochondrial transmembrane potential 
In both control cells, JC-1 aggregates with reddish 
fluorescence were obtained indicating a higher 
mitochondrial membrane potential. A concentration 
dependent rise in green and fall in red fluorescence 
for the plant extract in both cell lines after 24 h 
indicated a concentration dependent mitochondrial 
membrane potential drop (Figs 7 and 8).  
 
Bcl-2 gene expression study 
The relative Bcl-2 gene expression in MCF-7 and 
MDA-MB-231 cell line in response to addition of 
MEV at their respective IC50 concentrations as 
compared to control is presented in Fig. 9. In MDA-
MB-231 cells, Bcl-2 gene expression was decreased 
significantly (P <0.01) for the plant extract with  
0.36 ± 0.04 fold change in expression respectively 
when compared with the control. In MCF-7 cells,  
Bcl-2 gene expression when compared with the 
control decreased significantly (P <0.01) for MEV, 
with 0.89 ± 0.02 expression fold change respectively. 
Hence, it could be concluded that Bcl-2 gene 
expression was downregulated in both the cell lines 
after treatment with the plant extract.  
 
Western blot analysis 
Fig. 10 (A-D) represent the Western blot images of 
β-actin and Bcl-2 proteins in MDA-MB-231 and 
MCF-7 tumour cells, respectively. The expression of 
Bcl-2 protein in the control cells was normalized to 
unity. In comparison with the control, expression of 
Bcl-2 protein in MDA-MB-231 cells was decreased 
significantly (P <0.01) for the plant extract with 
0.39±0.01 fold change in expression. In MCF-7 cells, 
expression of Bcl-2 protein when compared with the 
control decreased significantly (P <0.01) for MEV, 
with 0.87±0.006 expression fold change. Hence, it 
could be concluded that expression of Bcl-2 protein 
was downregulated in both the carcinoma cell lines 
after treatment with the plant extract.  
 
Gas chromatography- high resolution mass spectroscopy  
(GC-HRMS) analysis 
Phytoconstituents obtained on GC-HRMS analysis of 
MEV are listed in Table 1. Methanol extract of  
E. variegata upon GC-HRMS analysis showed the 
presence of spathulenol, asarone, 3,7,11,15-tetramethyl 
2-hexadecen-1-ol, 17 octadecynoic acid, 1-hexadecanol, 
2-methyl, palmitic acid, heptacosanoic acid, methyl 
ester, 1-tricosanol, hexacosanoic acid methyl ester, 
octadecanoic acid, ethyl ester, and hexadecanoic acid, 
ethyl ester. The compounds were broadly belonging to 
terpenoids and fatty acid analogues.  
 
 
Fig. 6 — The apoptotic cell per cent of MDA-MB-231 and  
MCF-7 cells after treatment with methanol extract of E. variegata 
determined by Hoechst staining. [Values are expressed as  
Mean ± SE (n=6) Means with different superscripts differ 




Fig. 7 — Morphological changes of MDA-MB-231 cells studied 
by JC-1 staining 200X. A2, C2,E2,G2 and I2- JC-1 Red; B2, D2, 
F2, H2 and J2- JC-1 Green A2, B2- control cells; C2, D2- Cells 
treated with doxorubicin 0.58 μg/mL; E2, F2, G2,H2,I2, J2- cells 
treated with methanol extract of E. variegata at concentrations 
7.5, 15 and 30 μg/mL, respectively . 
 






Fig. 8 — Morphological changes of MCF-7 cells studied by JC-1 
staining, 200X. K2, M2,O2,Q2 and S2- JC-1 Red; L2, N2, P2, R2 
and T2- JC-1 Green K3, L2- control cells; M2, N2- Cells treated 
with doxorubicin 0.58 μg/mL; O2, P2, Q2, R2, S2, T2- cells 
treated with methanol extract of E. variegata at concentrations 
11.5, 23 and 46 μg/mL, respectively . 
 
Discussion 
Breast carcinoma, being one of the most frequently 
occurring types of carcinomas in humans, is 
responsible for majority of carcinoma related deaths
3
. 
Receptors for hormones like oestrogen and 
progesterone may either be present or absent in breast 
cancers owing the treatment options to be categorized 
broadly into hormone reactive and nonreactive 
types
25
. Comparing the types, hormone nonresponsive 
cancers are invasive, belligerent, and require 
 
 
Fig. 9 —The relative Bcl-2 gene in MDA-MB-231 and  
MCF-7 cells in response to treatment with methanol extract  
of E. variegata. [Values are expressed as Mean ± SE (n=3), 




Fig. 10 — (A-D) Western blot images of β- actin and Bcl-2 
proteins in MDA-MB-231 and MCF-7 cells. C and MEV are 
control cells and cells after treatment with MEV at its respective 
IC50 concentration. 
Table 1 — Gas chromatography- high resolution mass spectroscopy (GC-HRMS) analysis of phytochemicals  
in methanol extract of Erythrina variegata 
RT 
(min) 








17.32  Spathulenol  C15H24O 220 873820.24 Tricyclic sesquiterpene alcohol 8.48 
18.66 Asarone  C12H16O3 208 4266166.76 Ether 27.5 
21.86 3,7,11,15-Tetramethyl 2-hexadecen-1-ol C20H40O 296 2181822.81 Acyclic diterpene alcohol 13.4 
24.42 Palmitic acid C16H32O2 256 1120403.81 Saturated fatty acid 42 
28.33 17 Octadecynoic acid C18H32O2 280 910486.45 Fatty acid analogue 8.48 
37.11 1-Hexadecanol,2- methyl  C17H36O 256 4683005.50 Fatty alcohol 5.26 
37.55 Heptacosanoic acid, methyl ester  C29H56O2 454 780541.78 Fatty acid ester 14.5 
38.3 Hexadecanoic acid, ethyl ester C18H36O2 284 730614.78 Fatty acid ester 18.9 
39.82 1-tricosanol C23H48O 340 5689181.5 Fatty alcohol 7.88 
40.27 Hexacosanoic acid methyl ester C27H54O2 410 18921282.00 Fatty acid ester 32.4 
41.28 Octadecanoic acid, ethyl ester  C20H40O2 312 2294417.55 Fatty acid ester 26.8 




strenuous diagnosis demanding the availability of 
therapeutics effective in both the types. The current 
study was carried out in MDA-MB-231 and MCF-7 
cells to obtain apprehension on both hormone 
mediated and non-mediated carcinomas.  
Apart from the ancient records about E. variegata, 
there were also some preliminary scientific studies 
reported on the utility of E. variegata against certain 
cancers
26
. Nevertheless, an explicit understanding on 
how the plant acts has not been found out.  
In vitro antitumour potential of MEV was assessed 
initially in the cell lines using MTT assay. Viable 
cells alone are capable of reducing yellow MTT to 
insoluble purple formazan whose absorbance is 
measured
28
. According to NCI guidelines, substances 
having an IC50 less than 30 µg/mL could be 
considered as having potent cytotoxic action
28
. The 
IC50 values of the extract in both the cell lines are 
coming under this range. Henceforth, the extract 




MTT assay is incapacitated to detect the mode of 
inhibition of cell growth. Drugs mostly destroy cancer 
cells by apoptosis where apoptotic levels are 
positively regulated based on their sensitivity
30
. 
Apoptosis plays a pivotal role in the normal 
physiological growth and development stages by 
selective destruction of cells. Various therapeutic 
agents used against cancer activate signal transduction 
pathways associated with apoptosis
31
. The mechanism 
by which apoptosis is initiated by a therapeutic agent 
is not well understood. However, morphological and 
biochemical alterations like cellular shrinkage, 
nuclear fragmentation and marginalisation, chromatin 
condensation are characterised
32
. Apoptotic mediation 
of cell death was assessed using AO/EB dual staining 
which was reported to be used as an easier and 
economic tool for detecting apoptotic cells
33
. A 
marked variation between live, early, late apoptotic 
and necrotic cells could be identified. AO penetrates 
normal and early apoptotic cells, stains the nuclei 
green by binding to DNA while EB stains the nucleus 
of late apoptotic and necrotic cells red by securing to 
DNA fragments and apoptotic bodies
34
. 
Hoechst 33258 staining was performed to detect 
nuclear morphological changes due to MEV in MDA-
MB-231 and MCF-7 cells. Hoechst 33258 is a popular 
nuclear counter stain which binds to double stranded 
DNA, intercalates between adenine and thymine 
residues and causes emission of blue fluorescence. 
Apoptotic cells could be recognized among viable 
cells by the emission of bright blue fluorescence 
whereas latter emits uniform blue fluorescence
6
. 
Nuclear changes like marginalization, chromatin 
condensation, and nucleosomal ladder formation are 
detected during apoptosis by the action of caspases 
and other mitochondrial factors
35
. Evidences from the 
nuclear details along with dose enhanced apoptotic 




In intrinsic pathway, apoptosis occurs initially via 
Bcl-2 family protein activators localized in 
endoplasmic reticulum, nuclear and mitochondrial 
membranes. It leads to functional alteration in 
mitochondria due to fall in transmembrane potential. 
Apoptotic factors like cytochrome c will be released 




Apoptosis when occurs via intrinsic pathway 
causes reduction in mitochondrial membrane potential 
by effusion of apoptotic proteins
38
. JC-1 a cationic 
dye, accumulates in mitochondrial matrix to form red 
fluorescence aggregates owing to high mitochondrial 
membrane potential. As mitochondrial membrane 
potential lowers, red to green signal ratio decreases 
and per cent of green monomers increase. 
Cytotoxicity related to mitochondrial damage could 
be easily detected based on assessment of red to green 
signal ratio
39
. In the present study, MEV instigated a 
concentration relied lowering of ΔΨm by JC-1 
suggestive of mitochondria dependent intrinsic 
pathway of apoptosis. 
Bcl-2, an antiapoptotic gene belonging as second 
member of a group of proteins, is involved in release 
of proteins from intermitochondrial membrane
40
. It is 
an antiapoptotic protein occurring in association with 
β subunit of F1F0 ATPase in inner mitochondrial 
membrane
40
. It inhibits certain proapoptotic proteins 
which are involved in release and movement of 
cytochrome c and ROS involved in apoptotic cascade. 
Tawfik et al.
41
 reported 81 and 29% expression of 
Bcl-2 gene in triple negative and non-triple negative 
breast cancers, respectively. They can either be 
proapoptotic proteins like Bax and Bak, antiapoptotic 
molecules like Bcl-2, Bcl-xL. Bcl-2 acts by 
obstructing the outpour of cytochrome c from 




Expression of Bcl-2 gene and protein was down 
regulated significantly due to MEV in MDA-MB-231 






. The results depict the first report 
of the cellular mechanism of E. variegata extract 
behind the anticancer potential. 
GC-HRMS have evolved as a mainstream tool for 
qualitative and quantitative analysis of organic 
compounds. A combination of gas chromatography 
and mass spectrum division patterns with a database 
is utilized to detect phytoconstituents and relative 
peak area per cent method for quantitative estimation. 
Previous studies
44
 reported the presence of flavonoids, 
glycosides, alkaloids, tannins, steroids, phenolics  
and diterpenes in methanol extract of E. variegata 
upon analysing phytochemical constituents using 
biochemical tests. 
Out of the major chemicals detected in GC-HRMS, 
3,7,11,15-tetramethyl 2-hexadecen-1-ol, octadecanoic 
acid, eicosanoic acid and palmitic acid were 
previously reported
45
. Palmitic acid has potent 
antioxidant and 5α-reductase activity. Hexadecanoic 
acid ethyl ester has antioxidant, antiandrogenic and 
5α-reductase activity. According to Li et al.
46
, 
terpenoids possessed potent anticancer activity.  
 
Conclusion 
The results indicate that the methanol extract of 
stem bark of Erythrina variegata (MEV) possess 
anticancer potential in vitro against human breast 
cancer cell lines. The extract has been found to 
induce cytotoxicity through intrinsic apoptotic 
pathway as noted with AO/EB, Hoechst 33258 and 
JC-1 staining. The extract also downregulated  
Bcl-2 expression, the antiapoptotic gene and  
protein, which substantiated the observed apoptosis 
in vitro. Terpenoids obtained on GC-HRMS analysis 
be a contributing factor for the depicted anticancer 
activity in vitro. 
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